You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 6, August 12, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (94)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Ophthalmology
 •Ophthalmological Disorders
 •Cataracts/ Lens
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Association of Inhaled Corticosteroid Use With Cataract Extraction in Elderly Patients

Edeltraut Garbe, MD, MSc; Samy Suissa, PhD; Jacques LeLorier, MD, PhD, FRCPC

JAMA. 1998;280:539-543.

Context.— The use of systemic corticosteroids is a known risk factor for the development of cataracts.

Objective.— To determine whether treatment with inhaled corticosteroids is associated with cataract extraction in the elderly.

Design.— Case-control study.

Setting.— Quebec universal health insurance program for all elderly (provincial health insurance plan database [RAMQ database]).

Patients.— RAMQ enrollees 70 years and older. The 3677 cases were patients with a cataract extraction between 1992 and 1994. The 21868 controls were randomly selected from patients who did not have a diagnosis of cataract and matched to cases on the index date of the case.

Main Outcome Measures.— Odds ratio of cataract extraction in patients with prolonged cumulative exposure to inhaled corticosteroids compared with nonusers.

Results.— Excluding patients with systemic steroid treatment and after adjusting for age, sex, diabetes, systemic hypertension, glaucoma, ophthalmic steroids, and the number of physician claims for services, use of inhaled corticosteroids for more than 3 years was associated with undergoing cataract extraction (odds ratio [OR], 3.06; 95% confidence interval [CI], 1.53-6.13). For high average daily doses of beclomethasone or budesonide (>1 mg), the OR was elevated after more than 2 years of treatment (OR, 3.40; 95% CI, 1.49-7.76), whereas for low to medium doses (<=1 mg) of these drugs, the OR was 1.63 (95% CI, 0.85-3.13) after 2 years.

Conclusion.— Prolonged administration of high doses of inhaled corticosteroids increases the likelihood of undergoing cataract extraction in elderly patients. Further studies are needed to investigate the risk of developing cataracts for low to medium doses over longer periods.


From the Potsdam Institute of Pharmacoepidemiology and Technology Assessment, Potsdam, Germany (Dr Garbe); the Division of Clinical Epidemiology, Royal Victoria Hospital and the Department of Epidemiology and Biostatistics, McGill University (Dr Suissa) and the Centre de Recherche, Hôtel-Dieu de Montreal, Université de Montreal (Dr LeLorier), Montreal, Quebec.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Proximal Myopathy Associated With Inhaled Steroids

JAMA. ;281():37-37.
FULL TEXT  

Inhaled Corticosteroids and Likelihood of Cataract Extraction
, , , , , , , , , , , , , and
JAMA. ;281():791-793.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhaled corticosteroids in COPD: the case against
Suissa and Barnes
Eur Respir J 2009;34:13-16.
FULL TEXT  

Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance
Awan et al.
Br J Ophthalmol 2009;93:708-713.
ABSTRACT | FULL TEXT  

Medications to Modify Lung Function Decline in Chronic Obstructive Pulmonary Disease: Some Hopeful Signs
Suissa
Am. J. Respir. Crit. Care Med. 2008;178:322-323.
FULL TEXT  

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Suissa et al.
Proc Am Thorac Soc 2007;4:535-542.
ABSTRACT | FULL TEXT  

Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-based, Nested Case-Control Analysis
Schneider et al.
Am J Epidemiol 2006;164:881-889.
ABSTRACT | FULL TEXT  

Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Ernst et al.
Eur Respir J 2006;27:1168-1174.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes
Gartlehner et al.
Ann Fam Med 2006;4:253-262.
ABSTRACT | FULL TEXT  

How Pharmacogenomics Will Play a Role in the Management of Asthma
Wechsler and Israel
Am. J. Respir. Crit. Care Med. 2005;172:12-18.
FULL TEXT  

The Risk of Nonvertebral Fracture Related to Inhaled Corticosteroid Exposure Among Adults With Chronic Respiratory Disease
Johannes et al.
Chest 2005;127:89-97.
ABSTRACT | FULL TEXT  

Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Scanlon et al.
Am. J. Respir. Crit. Care Med. 2004;170:1302-1309.
ABSTRACT | FULL TEXT  

Categorizing Asthma Severity: An Overview of National Guidelines
Colice
Clin Med Res 2004;2:155-163.
ABSTRACT | FULL TEXT  

Pharmacological Management to Reduce Exacerbations in Adults With Asthma: A Systematic Review and Meta-analysis
Sin et al.
JAMA 2004;292:367-376.
ABSTRACT | FULL TEXT  

Systematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma: Collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology
Leone et al.
Chest 2003;124:2329-2340.
ABSTRACT | FULL TEXT  

A population based case-control study of cataract and inhaled corticosteroids
Smeeth et al.
Br J Ophthalmol 2003;87:1247-1251.
ABSTRACT | FULL TEXT  

Recent Advances and Future Frontiers in Treating Age-Related Cataracts
Solomon and Donnenfeld
JAMA 2003;290:248-251.
FULL TEXT  

Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
Sin and Man
Eur Respir J 2003;21:260-266.
ABSTRACT | FULL TEXT  

Potency of Inhaled Corticosteroid Fails to Predict Reduced Emergency Department Visits
Sin and Man
Arch Intern Med 2003;163:248-249.
FULL TEXT  

Low-Dose Inhaled Corticosteroid Therapy and Risk of Emergency Department Visits for Asthma
Sin and Man
Arch Intern Med 2002;162:1591-1595.
ABSTRACT | FULL TEXT  

Risk of Cataract in Patients Treated With Statins
Schlienger et al.
Arch Intern Med 2001;161:2021-2026.
ABSTRACT | FULL TEXT  

Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics
Sin and Tu
Eur Respir J 2001;17:380-385.
ABSTRACT | FULL TEXT  

Long-Term Effects of Budesonide or Nedocromil in Children with Asthma
The Childhood Asthma Management Program Research G
NEJM 2000;343:1054-1063.
ABSTRACT | FULL TEXT  

Low-Dose Inhaled Corticosteroids and the Prevention of Death from Asthma
Suissa et al.
NEJM 2000;343:332-336.
ABSTRACT | FULL TEXT  

Inhaled Corticosteroids and Likelihood of Cataract Extraction
Frantz et al.
JAMA 1999;281:791-793.
FULL TEXT  

Proximal Myopathy Associated With Inhaled Steroids
Herzog
JAMA 1999;281:37-37.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.